Volume 14, Number 3—March 2008
Research
Mycobacterium ulcerans Disease, Peru
Table 1
Case descriptions of Buruli ulcer, Peru*
Patient no. | Geographic origin | Age, y/sex | Patient delay, mo | Localized pain | No. of lesions | Sites | Size of main lesion, cm | Treatment |
---|---|---|---|---|---|---|---|---|
1 | Marañón | 18/M | 8 | Positive | 2 | Left knee | 7 × 6 | Lost to follow-up, no treatment |
2 | Huallaga | 22/F | 1 | Positive | 1 | Left thigh | 2 × 3 | Lost to follow-up, no treatment |
3 | Iquitos | 54/M | 2 | Positive | 2 (right knee earlier, larger) | Both knees | 6 × 7 | Antituberculous drugs and herbal medicines |
4 | Iquitos | 58/F | 8 | Positive | 5 (in a single group) | Left gluteal region | 12 × 16 (sum of all 5) | Anti-Leishmania and herbal medicines |
5 | Tumbes | 46/F | 8 | Positive | 2 (1 lesion was a scar) | Left foot | 5 × 6 | Lost to follow-up, no treatment |
6 | Iquitos | 21/F | 3 | Positive | 1 | Right thigh | 5 × 5 | Antituberculous drugs (regimen 1) and surgery |
7 | Tumbes | 34/F | 2 | Positive | 4 | Right thigh and leg | 6 × 8 | WHO BU antibiotics and surgery |
8 | Tumbes | 45/M | 1 | Positive | 2 | Right middle finger | 8 × 2 | Antituberculous drugs (regimen 1) and surgery |
*WHO, World Health Organization; BU, Buruli ulcer.